Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: New particulate Lyme disease vaccines

International Journal of Medical Microbiology

Volumn 298, Issue 1-2, 2008, Pages 135-142

  Nassal, Michael ^a   Skamel, Claudia ^a   Vogel, Maren ^a   Kratz, Peter A ^a   Stehle, Thomas ^b   Wallich, Reinhard ^c   Simon, Markus M ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adjuvant; Capsid like particles; HBcAG; Lyme borreliosis; Osp vaccine; Particulate carrier

Indexed keywords

BACTERIAL PROTEIN; CAPSID PROTEIN; DIMER; EPITOPE; IMMUNOGLOBULIN CLASS; LYME DISEASE VACCINE; NANOPARTICLE; OUTER SURFACE PROTEIN A; PROTEIN OSPC; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BORRELIA BURGDORFERI; DIMERIZATION; DRUG DESIGN; DRUG POTENCY; HEPATITIS B VIRUS; IMMUNOGENICITY; IMMUNOMODULATION; LYME DISEASE; NONHUMAN; PROTEIN ASSEMBLY; SHORT SURVEY; VIRUS CAPSID; VIRUS PARTICLE;

EID: 36749022937     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2007.08.002     Document Type: Short Survey

References (70)

1. Beck J., and Nassal M. Hepatitis B virus replication. World J. Gastroenterol. 13 (2007) 48-64
2. Belnap D.M., Watts N.R., Conway J.F., Cheng N., Stahl S.J., Wingfield P.T., and Steven A.C. Diversity of core antigen epitopes of hepatitis B virus. Proc. Natl. Acad. Sci. USA 100 (2003) 10884-10889
3. Birkett A., Lyons K., Schmidt A., Boyd D., Oliveira G.A., Siddique A., Nussenzweig R., Calvo-Calle J.M., and Nardin E. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect. Immun. 70 (2002) 6860-6870
4. Birnbaum F., and Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J. Virol. 64 (1990) 3319-3330
5. Blumberg B.S. Hepatitis B virus, the vaccine, and the control of primary cancer of the liver. Proc. Natl. Acad. Sci. USA 94 (1997) 7121-7125
6. Böttcher B., Wynne S.A., and Crowther R.A. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386 (1997) 88-91
7. Böttcher B., Vogel M., Ploss M., and Nassal M. High plasticity of the hepatitis B virus capsid revealed by conformational stress. J. Mol. Biol. 356 (2006) 812-822
8. Cao T., Lazdina U., Desombere I., Vanlandschoot P., Milich D.R., Sällberg M., and Leroux-Roels G. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model. J. Virol. 75 (2001) 6359-6366
9. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13 (1995) 29-60
10. Clarke B.E., Newton S.E., Carroll A.R., Francis M.J., Appleyard G., Syred A.D., Highfield P.E., Rowlands D.J., and Brown F. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330 (1987) 381-384
11. Conway J.F., Cheng N., Zlotnick A., Wingfield P.T., Stahl S.J., and Steven A.C. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature 386 (1997) 91-94
12. Conway J.F., Cheng N., Zlotnick A., Stahl S.J., Wingfield P.T., Belnap D.M., Kanngiesser U., Noah M., and Steven A.C. Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78-83) on the capsid surface, and implications for the distinction between c and e-antigens. J. Mol. Biol. 279 (1998) 1111-1121
13. Crowther R.A., Kiselev N.A., Böttcher B., Berriman J.A., Borisova G.P., Ose V., and Pumpens P. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77 (1994) 943-950
14. de Silva A.M., Telford III S.R., Brunet L.R., Barthold S.W., and Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183 (1996) 271-275
15. Eicken C., Sharma V., Klabunde T., Owens R.T., Pikas D.S., Hook M., and Sacchettini J.C. Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi. J. Biol. Chem. 276 (2001) 10010-10015
16. Fehr T., Skrastina D., Pumpens P., and Zinkernagel R.M. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc. Natl. Acad. Sci. USA 95 (1998) 9477-9481
17. Fikrig E., Barthold S.W., Kantor F.S., and Flavell R.A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250 (1990) 553-556
18. Fikrig E., Feng W., Barthold S.W., Telford III S.R., and Flavell R.A. Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J. Immunol. 164 (2000) 5344-5351
19. Fraser C.M., Casjens S., Huang W.M., Sutton G.G., Clayton R., Lathigra R., White O., Ketchum K.A., Dodson R., Hickey E.K., Gwinn M., Dougherty B., Tomb J.F., Fleischmann R.D., Richardson D., Peterson J., Kerlavage A.R., Quackenbush J., Salzberg S., Hanson M., van Vugt R., Palmer N., Adams M.D., Gocayne J., Weidman J., Utterback T., Watthey L., McDonald L., Artiach P., Bowman C., Garland S., Fuji C., Cotton M.D., Horst K., Roberts K., Hatch B., Smith H.O., and Venter J.C. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390 (1997) 580-586
20. Fuchs H., Wallich R., Simon M.M., and Kramer M.D. The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor. Proc. Natl. Acad. Sci. USA 91 (1994) 12594-12598
21. Geldmacher A., Skrastina D., Borisova G., Petrovskis I., Krüger D.H., Pumpens P., and Ulrich R. A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies. Vaccine 23 (2005) 3973-3983
22. Grgacic E.V., and Anderson D.A. Virus-like particles: passport to immune recognition. Methods 40 (2006) 60-65
23. Harro C.D., Pang Y.Y., Roden R.B., Hildesheim A., Wang Z., Reynolds M.J., Mast T.C., Robinson R., Murphy B.R., Karron R.A., Dillner J., Schiller J.T., and Lowy D.R. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. 93 (2001) 284-292
24. Kazaks A., Lachmann S., Koletzki D., Petrovskis I., Dislers A., Ose V., Skrastina D., Gelderblom H.R., Lundkvist A., Meisel H., Borisova G., Krüger D.H., Pumpens P., and Ulrich R. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions. Intervirology 45 (2002) 340-349
25. Kenney J.M., von Bonsdorff C.H., Nassal M., and Fuller S.D. Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores. Structure 3 (1995) 1009-1019
26. Koletzki D., Biel S.S., Meisel H., Nugel E., Gelderblom H.R., Krüger D.H., and Ulrich R. HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. Biol. Chem. 380 (1999) 325-333
27. Koletzki D., Lundkvist A., Sjolander K.B., Gelderblom H.R., Niedrig M., Meisel H., Krüger D.H., and Ulrich R. Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles. Virology 276 (2000) 364-375
28. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., Chiacchierini L.M., and Jansen K.U. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347 (2002) 1645-1651
29. Kraiczy P., Hellwage J., Skerka C., Becker H., Kirschfink M., Simon M.M., Brade V., Zipfel P.F., and Wallich R. Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J. Biol. Chem. 279 (2004) 2421-2429
30. Kratz P.A., Böttcher B., and Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc. Natl. Acad. Sci. USA 96 (1999) 1915-1920
31. Kumaran D., Eswaramoorthy S., Luft B.J., Koide S., Dunn J.J., Lawson C.L., and Swaminathan S. Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi. EMBO J. 20 (2001) 971-978
32. Lazdina U., Cao T., Steinbergs J., Alheim M., Pumpens P., Peterson D.L., Milich D.R., Leroux-Roels G., and Sällberg M. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J. Virol. 75 (2001) 6367-6374
33. Lazdina U., Alheim M., Nystrom J., Hultgren C., Borisova G., Sominskaya I., Pumpens P., Peterson D.L., Milich D.R., and Sällberg M. Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent. J. Gen. Virol. 84 (2003) 139-146
34. Li H., Dunn J.J., Luft B.J., and Lawson C.L. Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab. Proc. Natl. Acad. Sci. USA 94 (1997) 3584-3589
35. Marconi R.T., Samuels D.S., and Garon C.F. Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes. J. Bacteriol. 175 (1993) 926-932
36. Milich D.R., and McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234 (1986) 1398-1401
37. Milich D.R., Chen M., Schödel F., Peterson D.L., Jones J.E., and Hughes J.L. Role of B cells in antigen presentation of the hepatitis B core. Proc. Natl. Acad. Sci. USA 94 (1997) 14648-14653
38. Nassal M. Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization. Gene 66 (1988) 279-294
39. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J. Virol. 66 (1992) 4107-4116
40. Nassal M. Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology 42 (1999) 100-116
41. Nassal M. Macromolecular interactions in hepatitis B virus replication and particle assembly. In: Cann A.J. (Ed). DNA Virus Replication. Frontiers in Molecular Biology (2000), Oxford University Press, Oxford, UK 1-40
42. Nassal M., Skamel C., Kratz P.A., Wallich R., Stehle T., and Simon M.M. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Eur. J. Immunol. 35 (2005) 655-665
43. Noad R., and Roy P. Virus-like particles as immunogens. Trends Microbiol. 11 (2003) 438-444
44. Ormo M., Cubitt A.B., Kallio K., Gross L.A., Tsien R.Y., and Remington S.J. Crystal structure of the Aequorea victoria green fluorescent protein. Science 273 (1996) 1392-1395
45. Pumpens P., and Grens E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 44 (2001) 98-114
46. Ramamoorthi N., Narasimhan S., Pal U., Bao F., Yang X.F., Fish D., Anguita J., Norgard M.V., Kantor F.S., Anderson J.F., Koski R.A., and Fikrig E. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436 (2005) 573-577
47. Salfeld J., Pfaff E., Noah M., and Schaller H. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J. Virol. 63 (1989) 798-808
48. Sällberg M., Hughes J., Jones J., Phillips T.R., and Milich D.R. A malaria vaccine candidate based on a hepatitis B virus core platform. Intervirology 45 (2002) 350-361
49. Schaible U.E., Kramer M.D., Eichmann K., Modolell M., Museteanu C., and Simon M.M. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc. Natl. Acad. Sci. USA 87 (1990) 3768-3772
50. Schödel F., Moriarty A.M., Peterson D.L., Zheng J.A., Hughes J.L., Will H., Leturcq D.J., McGee J.S., and Milich D.R. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J. Virol. 66 (1992) 106-114
51. Schwan T.G., Piesman J., Golde W.T., Dolan M.C., and Rosa P.A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 92 (1995) 2909-2913
52. Sigal L.H., Zahradnik J.M., Lavin P., Patella S.J., Bryant G., Haselby R., Hilton E., Kunkel M., Adler-Klein D., Doherty T., Evans J., Molloy P.J., Seidner A.L., Sabetta J.R., Simon H.J., Klempner M.S., Mays J., Marks D., and Malawista S.E. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N. Engl. J. Med. 339 (1998) 216-222
53. Simon M.M., Schaible U.E., Kramer M.D., Eckerskorn C., Museteanu C., Müller-Hermelink H.K., and Wallich R. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 164 (1991) 123-132
54. Simon M.M., Gern L., Hauser P., Zhong W., Nielsen P.J., Kramer M.D., Brenner C., and Wallich R. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur. J. Immunol. 26 (1996) 2831-2840
55. Skamel C., Ploss M., Böttcher B., Stehle T., Wallich R., Simon M.M., and Nassal M. Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection. J. Biol. Chem. 281 (2006) 17474-17481
56. Steere A.C., and Glickstein L. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4 (2004) 143-152
57. Steere A.C., Sikand V.K., Meurice F., Parenti D.L., Fikrig E., Schoen R.T., Nowakowski J., Schmid C.H., Laukamp S., Buscarino C., and Krause D.S. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N. Engl. J. Med. 339 (1998) 209-215
58. Steere A.C., Coburn J., and Glickstein L. The emergence of Lyme disease. J. Clin. Invest. 113 (2004) 1093-1101
59. Steven A.C., Conway J.F., Cheng N., Watts N.R., Belnap D.M., Harris A., Stahl S.J., and Wingfield P.T. Structure, assembly, and antigenicity of hepatitis B virus capsid proteins. Adv. Virus Res. 64 (2005) 125-164
60. Stray S.J., Bourne C.R., Punna S., Lewis W.G., Finn M.G., and Zlotnick A. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc. Natl. Acad. Sci. USA 102 (2005) 8138-8143
61. Ulrich R., Nassal M., Meisel H., and Krüger D.H. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus Res. 50 (1998) 141-182
62. Ulrich R., Koletzki D., Lachmann S., Lundkvist A., Zankl A., Kazaks A., Kurth A., Gelderblom H.R., Borisova G., Meisel H., and Krüger D.H. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge. J. Biotechnol. 73 (1999) 141-153
63. Van Hoecke C., Comberbach M., De Grave D., Desmons P., Fu D., Hauser P., Lebacq E., Lobet Y., and Voet P. Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults. Vaccine 14 (1996) 1620-1626
64. Vogel M., Vorreiter J., and Nassal M. Quaternary structure is critical for protein display on capsid-like particles (CLPs): efficient generation of hepatitis B virus CLPs presenting monomeric but not dimeric and tetrameric fluorescent proteins. Proteins 58 (2005) 478-488
65. Wallich R., Brenner C., Kramer M.D., and Simon M.M. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect. Immun. 63 (1995) 3327-3335
66. Watts N.R., Conway J.F., Cheng N., Stahl S.J., Belnap D.M., Steven A.C., and Wingfield P.T. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J. 21 (2002) 876-884
67. Wynne S.A., Crowther R.A., and Leslie A.G. The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3 (1999) 771-780
68. Zhang J.R., Hardham J.M., Barbour A.G., and Norris S.J. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89 (1997) 275-285
69. Zhong W., Stehle T., Museteanu C., Siebers A., Gern L., Kramer M., Wallich R., and Simon M.M. Therapeutic passive vaccination against chronic Lyme disease in mice. Proc. Natl. Acad. Sci. USA 94 (1997) 12533-12538
70. Zhong W., Gern L., Stehle T., Museteanu C., Kramer M., Wallich R., and Simon M.M. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur. J. Immunol. 29 (1999) 946-957